• Search Research Projects
  • Search Researchers
  • How to Use
  1. Back to previous page

Analysis of novel Alzheimer's disease-related peptides in human cerebrospinal fluid derived from APLP2

Research Project

Project/Area Number 23591704
Research Category

Grant-in-Aid for Scientific Research (C)

Allocation TypeMulti-year Fund
Section一般
Research Field Psychiatric science
Research InstitutionOsaka University

Principal Investigator

YANAGIDA Kanta  大阪大学, 医学(系)研究科(研究院), 研究員 (70467596)

Co-Investigator(Kenkyū-buntansha) OKOCHI Masayasu  大阪大学, 医学(系)研究科(研究院), 講師 (90335357)
TAGAMI Shinji  大阪大学, 医学(系)研究科(研究院), 助教 (40362735)
KODAMA Takashi  大阪大学, 医学(系)研究科(研究院), 研究員 (30512131)
Project Period (FY) 2011 – 2013
Project Status Completed (Fiscal Year 2013)
Budget Amount *help
¥5,070,000 (Direct Cost: ¥3,900,000、Indirect Cost: ¥1,170,000)
Fiscal Year 2013: ¥1,300,000 (Direct Cost: ¥1,000,000、Indirect Cost: ¥300,000)
Fiscal Year 2012: ¥1,560,000 (Direct Cost: ¥1,200,000、Indirect Cost: ¥360,000)
Fiscal Year 2011: ¥2,210,000 (Direct Cost: ¥1,700,000、Indirect Cost: ¥510,000)
Keywordsアルツハイマー病 / アミロイド / セクレターゼ / 脳神経疾患 / アミロイドβ
Research Abstract

Previously, we detected APLP2-derived Abeta like peptides APL2beta35, 38 and 39 from human Cerebrospinal Fluid. To clarify generation mechanism of APL2beta, APLP2 transfected cells were treated with several secretase inhibitors. Secreted peptides were immunoprecipitated by anti-APL2beta antisera and detected by MALDI-TOF Ms. APL2beta peptides were abolished by beta- and gamma-secretase inhibitors. Conversely, APL2beta38 and 39, but not APL2beta35 were raised by alpha-secretase inhibitor. Interestingly, APL2beta35 was increased, but APL2beta38 and 39 were decreased by overexpression of Neprilysin, which is known as major Abeta degrading enzyme in brain. These results indicate that APL2beta38 and 39 are generated by beta- and gamma-secretase, and cleaved by Neprilysin. Consequently, APL2beta35 is produced. It is considered that Neprilysin is reduced in the brains of Alzheimer disease patients. Thus, APL2beta35 may be a surrogate marker for Abeta degradation by Neprilysin in brain.

Report

(4 results)
  • 2013 Annual Research Report   Final Research Report ( PDF )
  • 2012 Research-status Report
  • 2011 Research-status Report
  • Research Products

    (9 results)

All 2013 2012 2011 Other

All Presentation (9 results)

  • [Presentation] Identification of APLP2-derived Aβ-like peptides from human Cerebrospinal fluid2013

    • Author(s)
      柳田寛太
    • Organizer
      WFSBP Congress 2013
    • Place of Presentation
      国立京都国際会館
    • Year and Date
      2013-06-27
    • Related Report
      2013 Annual Research Report 2013 Final Research Report
  • [Presentation] APLP2はPresenilin1 FAD mutantによってβAPPやAPLP1と異なる切断を受ける2013

    • Author(s)
      柳田寛太
    • Organizer
      Neuro2013
    • Place of Presentation
      国立京都国際会館
    • Year and Date
      2013-06-21
    • Related Report
      2013 Final Research Report
  • [Presentation] APL2βの産生メカニズムの解析(1)APLP2はプレセニリン1と2で異なる切断を受ける2012

    • Author(s)
      柳田寛太
    • Organizer
      第30回日本認知症学会学術集会
    • Place of Presentation
      つくば国際会議場
    • Year and Date
      2012-10-26
    • Related Report
      2013 Final Research Report
  • [Presentation] APL2βの産生メカニズムの解析(2)APL2βはネプリライシンで切断される2012

    • Author(s)
      柳田寛太
    • Organizer
      第30回日本認知症学会学術集会
    • Place of Presentation
      つくば国際会議場
    • Year and Date
      2012-10-26
    • Related Report
      2013 Final Research Report
  • [Presentation] APL2βの産生メカニズムの解析(1)APLP2はプレセニリン1と2で異なる切断を受ける2012

    • Author(s)
      柳田寛太
    • Organizer
      第31回日本認知症学会学術集会
    • Place of Presentation
      つくば国際会議場
    • Related Report
      2012 Research-status Report
  • [Presentation] APL2βの産生メカニズムの解析(2)APL2βはネプリライシンで切断される2012

    • Author(s)
      柳田寛太
    • Organizer
      第31回日本認知症学会学術集
    • Place of Presentation
      つくば国際会議場
    • Related Report
      2012 Research-status Report
  • [Presentation] APPファミリータンパクは脳内では主にBACEによってsheddingを受けるが培養細胞に過剰発現させるとα-セクレターゼによる切断が増加する2011

    • Author(s)
      柳田寛太
    • Organizer
      第30回日本認知症学会学術集会
    • Place of Presentation
      タワーホール船堀
    • Year and Date
      2011-11-11
    • Related Report
      2013 Final Research Report
  • [Presentation] βAPPファミリータンパクは脳内では主にBACEによってsheddingを受けるが培養細胞に過剰発現させるとα-セクレターゼによる切断が増加する2011

    • Author(s)
      柳田寛太
    • Organizer
      第30回日本認知症学会学術集会
    • Place of Presentation
      タワーホール船橋(東京)
    • Related Report
      2011 Research-status Report
  • [Presentation] APLP2はPresenilin1 FAD mutantによってβAPPやAPLP1と異なる切断を受ける。

    • Author(s)
      柳田寛太
    • Organizer
      Neuro2013
    • Place of Presentation
      国立京都国際会館
    • Related Report
      2013 Annual Research Report

URL: 

Published: 2011-08-05   Modified: 2019-07-29  

Information User Guide FAQ News Terms of Use Attribution of KAKENHI

Powered by NII kakenhi